NCT03590574 2026-03-16Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell LymphomaAutolus LimitedPhase 1/2 Terminated20 enrolled 34 charts
NCT03493451 2024-10-26Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell NeoplasmsBeiGenePhase 2 Completed77 enrolled 20 charts
NCT02273739 2021-02-23Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCelgenePhase 1/2 Completed21 enrolled 33 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts